ArticleACS medicinal chemistry letters2025

Targeted Degradation of BCL6 Using Novel Bifunctional Degraders: A New Therapeutic Strategy for BCL6-Positive Cancers.

Robert B KargboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.